Sarepta Therapeutics (SRPT) Stock Chart & Stock Price History $106.28 -2.13 (-1.96%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$106.22 -0.06 (-0.06%) As of 02/21/2025 07:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Sarepta Therapeutics Stock Price Performance 5 Day Performance-1.55%1 Month Performance-8.45%3 Month Performance-6.96%6 Month Performance-24.85%Year-To-Date Performance-12.59%1 Year Performance-21.15% Receive SRPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sarepta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address SRPT Stock Chart for Saturday, February, 22, 2025 SRPT Chart by TradingView Sarepta Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025$108.41$106.28-1.96%$110.00$106.02709,268 shs$10.15 billion02/20/2025$107.12$108.41+1.20%$109.83$105.93836,109 shs$10.36 billion02/19/2025$105.35$107.12+1.68%$107.46$104.74713,510 shs$10.23 billion02/18/2025$107.95$105.35-2.41%$106.10$101.151.31 million shs$10.06 billion02/17/2025$107.95$107.95$111.21$107.61630,697 shs$10.31 billion02/14/2025$109.46$107.95-1.38%$111.21$107.61630,697 shs$10.31 billion02/13/2025$109.81$109.46-0.32%$110.11$107.74712,618 shs$10.46 billion02/12/2025$109.68$109.81+0.12%$110.34$108.17639,513 shs$10.49 billion02/11/2025$112.74$109.68-2.71%$111.59$109.55654,216 shs$10.48 billion02/10/2025$111.82$112.74+0.82%$114.41$110.81604,097 shs$10.77 billion Get the Latest News and Ratings for SRPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sarepta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025$112.11$111.82-0.26%$112.37$109.52881,445 shs$10.68 billion02/06/2025$119.02$112.11-5.81%$119.27$112.06886,375 shs$10.71 billion02/05/2025$114.08$119.02+4.33%$120.05$114.46842,350 shs$11.37 billion02/04/2025$113.81$114.08+0.24%$115.12$112.87563,571 shs$10.90 billion02/03/2025$113.72$113.81+0.08%$114.80$111.48604,263 shs$10.87 billion01/31/2025$114.45$113.72-0.64%$116.15$112.78724,636 shs$10.86 billion01/30/2025$115.45$114.45-0.87%$116.24$113.46767,883 shs$10.93 billion01/29/2025$117.51$115.45-1.75%$117.50$113.38904,962 shs$11.03 billion01/28/2025$116.89$117.51+0.53%$118.28$116.541.22 million shs$11.22 billion01/27/2025$116.46$116.89+0.37%$119.44$116.31858,011 shs$11.17 billion01/24/2025$119.14$116.46-2.25%$119.00$116.001.13 million shs$11.38 billion01/23/2025$116.09$119.14+2.63%$120.00$114.06794,818 shs$11.38 billion01/22/2025$116.79$116.09-0.60%$118.20$115.50731,704 shs$11.09 billion01/21/2025$118.00$116.79-1.03%$119.51$116.211.20 million shs$11.16 billion Related Companies argenx Stock Chart BioNTech Stock Chart Beigene Stock Chart Teva Pharmaceutical Industries Stock Chart Summit Therapeutics Stock Chart Genmab A/S Stock Chart Intra-Cellular Therapies Stock Chart Viatris Stock Chart Moderna Stock Chart Dr. Reddy's Laboratories Stock Chart Receive SRPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sarepta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SRPT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredA strange twist 500 miles from WashingtonEnergy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sarepta Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sarepta Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
